• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Andrew Payne
Andrew Payne
Andrew Payne

Andrew Payne

Partner

  • London UK
Contact Me Today
+44 207 300 7145
vCard
Email me Call me
Featured award

Legal 500

Intellectual Property: patents (contentious & non-contentious) - "Andrew has been identified as a key name to note."

Scroll to featured award

Andrew is a partner in the Patents & Innovation team and offers expert counsel on contentious patent and regulatory matters.

Leveraging his previous experience as a medicinal chemist in the pharmaceutical industry, he is particularly focused on advising companies within the life sciences sector and is recognised by clients for his extensive industry knowledge.

Expertise

Services and Groups

Patents & innovation
Commercial & consumer contracts
Disputes & investigations
Resolving patents & know-how disputes
Advising on life sciences regulation
Drafting and negotiating patents & know-how commercial agreements
IP disputes
Commercial disputes

Sectors

Life sciences & healthcare
Chemicals
Manufacturing & industrials
Biotech
Medical devices
Life sciences start-ups and investors
Pharmaceuticals

CV

Since 2025 Partner, Taylor Wessing
2024 - 2025 Senior Counsel, Taylor Wessing
2020 - 2024 Senior Associate, Taylor Wessing
2015 - 2020 Associate, Taylor Wessing
2013 - 2015 Trainee Solicitor , CMS Cameron McKenna
2009 - 2013 Group Leader, Medicinal Chemistry at Eisai
2000 - 2009 Team Leader, GlaxoSmithKline
1998 - 1999 Postdoctoral Researcher, The University of Texas at Austin
2015 Admitted as a lawyer, England & Wales
2013 LPC distinction, BPP Law School
2011 GDL commendation, BPP Law School, London
1997 PhD in synthetic organic chemistry from Imperial College, London
1994 BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy

Career

Since 2025 Partner, Taylor Wessing
2024 - 2025 Senior Counsel, Taylor Wessing
2020 - 2024 Senior Associate, Taylor Wessing
2015 - 2020 Associate, Taylor Wessing
2013 - 2015 Trainee Solicitor , CMS Cameron McKenna
2009 - 2013 Group Leader, Medicinal Chemistry at Eisai
2000 - 2009 Team Leader, GlaxoSmithKline
1998 - 1999 Postdoctoral Researcher, The University of Texas at Austin

Education

2015 Admitted as a lawyer, England & Wales
2013 LPC distinction, BPP Law School
2011 GDL commendation, BPP Law School, London
1997 PhD in synthetic organic chemistry from Imperial College, London
1994 BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy

Publications

Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128
Patents Overhauled: Impact of the America Invents Act on the Pharmaceutical Industry (co-author), European Biopharmaceutical Review, Spring 2015
New and Approved: The New EU Clinical Trials Regulation (co-author), European Pharmaceutical Contractor, December 2014 p 50-53

Additional languages

Italian Spanish

Awards

Legal 500

Featured

Intellectual Property: patents (contentious & non-contentious) - "Andrew has been identified as a key name to note."

Andrew's news & insights

View Andrew's insights
UPC
Click here to find out more
UPC

The UK and the Unified Patent Court, two years in - how can long-arm reach be prevented in the UK?

4 June 2025

by Dr Paul England and Andrew Payne

Glass.Mapper.Sc.Fields.Image?.Alt
Patents & innovation

Dealing with difficult service in the UPC: The cases of Philips IP Ventures v Belkin and Panasonic v Xiaomi as examples.

24 January 2024
In-depth analysis

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Life sciences & healthcare

Brexit and beyond – Wellcome's recommendations from the Future Partnership Project

30 March 2018
Briefing

by Andrew Payne

Click here to find out more
View Andrew's insights

Related news & insights

Tech Takes Monthly
Patents & innovation

The development of the UK's SEP/FRAND landscape since Unwired Planet v Huawei – part one

30 January 2026
Briefing

by multiple authors

Click here to find out more
Tech Takes Monthly
Patents & innovation

Tech Takes Monthly series

30 January 2026
Quick read
Click here to find out more
Close-Up Of Modern Office Facade
Corporate/M&A & capital markets

Taylor Wessing advises Multiverse Group Limited and Multiverse GmbH on the acquisition of StackFuel GmbH

29 January 2026

by multiple authors

Click here to find out more
Hand Holding Blue Paper Airplane on green background
Careers

Oli Denne recognised in The Lawyer's Hot 100 2026

28 January 2026

by Oli Denne and Shane Gleghorn

Click here to find out more
Overhead view of scientist using centrifuge machine
Life sciences & healthcare

Research and innovation as a competitive advantage – Legal framework for Life Sciences made in Europe

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Patterned pills
Life sciences & healthcare

Life Sciences Made in Europe – The European Commission’s Life Sciences Strategy 2030

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Blood samples
Life sciences & healthcare

Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices

23 January 2026
Briefing

by Irina Rebin and Daniel Dietrich

Click here to find out more
Tunnel
Disputes & investigations

Key developments in AI disputes in 2025

23 January 2026
Briefing

by multiple authors

Click here to find out more
Low Angle View Of Flags Waving
Logistics & transport

EU Inc.: Founders and companies with expansion plans must now think strategically

23 January 2026
Quick read

by Dr. Benedikt Groh and Fritz Krings

Click here to find out more
Office facade reflection
Life sciences & healthcare

Advising Nuclera on its extended Series C funding to US$87 million

22 January 2026

by Ross McNaughton and Oli Denne

Click here to find out more
View all insights

Related people

UK
Global
Richard Miles

Dr Richard Miles

Associate

London
+44 20 7300 7000
Email me
View profile
Fionnuala Richardson

Fionnuala Richardson

Associate

London
+44 20 7300 7000
Email me
View profile
Ed Vickers

Edward Vickers

Senior Counsel

London
+44 20 7300 7000
Email me
View profile
Charlie Madill

Charlie Madill

Associate

London
+44 20 7300 7000
Email me
View profile
Nigel Stoate

Nigel Stoate

Partner

London
+44 20 7300 4783
Email me
View profile
Amanda Ebbutt

Amanda Ebbutt

Partner

London
+44 20 7300 7130
Email me
View profile
Alice Matthews

Alice Matthews

Associate

London
+44 20 7300 7000
Email me
View profile
Matthew Royle

Matthew Royle, Ph.D.

Partner

London
Dublin
+44 20 7300 4608
Email me
View profile

David de Ferrars

Partner

London
+44 20 7300 4883
Email me
View profile
Christopher Thornham

Chris Thornham

Partner

London
+44 20 7300 4817
Email me
View profile
Full team
Max Kempe

Max Kempe

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Marine Boullenger

Marine Boullenger

Associate

Paris
+33 1 72 74 03 33
View profile
Pauline Springorum

Pauline Springorum

Associate

Amsterdam
+31 88 02 43 203
Email me
View profile
Dr. Michael Kieffer

Dr. Michael Kieffer

Partner

Munich
+49 89 21038 0
Email me
View profile
Dr. Martin Rothermel

Dr. Martin Rothermel

Partner

Munich
+49 89 21038 0
Email me
View profile
Margot van Gerwen

Margot van Gerwen

Partner

Eindhoven
+31 88 02 43 112
Email me
View profile
Rebecca Limer

Rebecca Limer

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Alexandra Boreham

Alexandra Boreham

Associate

London
+44 20 7300 7000
Email me
View profile
Maxime de Jong

Maxime de Jong

Associate

Eindhoven
+31 88 02 43 162
Email me
View profile
Mark Goorts

Mark Goorts

Partner

Eindhoven
+31 88 02 43 051
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing